Over-the-counter (OTC) ß2-agonist purchase is not associated with poor asthma control: a random, community study

J. Douglass, D. Goeman, S. Sawyer, R. Aroni, K. Stewart, M. Abramson (Melbourne, Australia)

Source: Annual Congress 2006 - Asthma management, severity and quality of life
Session: Asthma management, severity and quality of life
Session type: Thematic Poster Session
Number: 3963
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Douglass, D. Goeman, S. Sawyer, R. Aroni, K. Stewart, M. Abramson (Melbourne, Australia). Over-the-counter (OTC) ß2-agonist purchase is not associated with poor asthma control: a random, community study. Eur Respir J 2006; 28: Suppl. 50, 3963

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Suboptimal asthma control among over-the-counter reliever purchasers in the community pharmacy.
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019

Persistent asthma: disease control, resource utilisation and direct costs
Source: Eur Respir J 2002; 20: 260-267
Year: 2002



Patients‘ perceptions of asthma inhalers: a national (UK) survey
Source: Annual Congress 2005 - Assessment and intervention from primary care centre to hospital
Year: 2005


Detecting problems of patients with asthma: a community problem with a community approach
Source: Annual Congress 2006 - Connecting with the community: collaborations that work
Year: 2006


Medication use in children with asthma: a case control study
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001

What predicts poor collection of medication among children with asthma? A case-control study
Source: Eur Respir J 2002; 20: 1464-1469
Year: 2002



SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting ß2-agonist use in asthma
Source: Eur Respir J, 55 (2) 1901858; 10.1183/13993003.01858-2019
Year: 2020



Effectiveness of N-acetyl cyctein (NAC) to reduce cough when used together with other over-the-counter (OTC) in common cold (a preliminary study)
Source: Annual Congress 2008 - Advances in the treatment and pathogenesis of pulmonary diseases
Year: 2008

Global asthma physician & patient (GAPP) survey: satisfaction with current asthma medications in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006


Improvement in asthma control and reduction in medical resource use following treatment with montelukast (PRAACTICAL Study)
Source: Eur Respir J 2005; 26: Suppl. 49, 576s
Year: 2005

Main reasons of poor asthma control in children with severe asthma (Tomsk study)
Source: Eur Respir J 2001; 18: Suppl. 33, 267s
Year: 2001

Poor perceptions of asthma control: results of the international control of asthma symptoms (ICAS) GP survey
Source: Eur Respir J 2004; 24: Suppl. 48, 83s
Year: 2004

Medication use and disease control of asthma patients in Flanders: a cross-sectional community pharmacy study
Source: Eur Respir J 2005; 26: Suppl. 49, 47s
Year: 2005

Use of household cleaning sprays and new-onset asthma: a community-based study in 10 European countries
Source: Annual Congress 2005 - Cleaning and cooking: a risk for occupational and household asthma
Year: 2005


Improving adherence to asthma medications: same-old, same-old?
Source: Eur Respir J, 57 (6) 2004284; 10.1183/13993003.04284-2020
Year: 2021



Small-group asthma education in the community pharmacy setting: a pilot study
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006


A 1-day visit in a severe asthma centre: effect on asthma control, quality of life and healthcare use
Source: Eur Respir J 2016; 48: 726-733
Year: 2016



Poor perceptions and expectations of asthma control: results of the international control of asthma symptoms (ICAS) patient survey
Source: Eur Respir J 2004; 24: Suppl. 48, 83s
Year: 2004

Healthcare costs associated with short-acting ß2-agonist use in asthma: an observational UK study from the SABINA global programme
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Asthma severity, poor control, co-morbidities and prior resource use determined omalizumab prescriptions in a nested case-control study with US claims data
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015